Market Highlights
High Throughput Screening Market Size was evaluated at USD 8.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% between 2023 and 2032, from USD 17.45 billion in 2023 to USD 113.3 billion by 2032.
High throughput screening has achieved mainstream acceptance over the past two decades and has become a traditional drug discovery tool in the pharmaceutical industry. Factors such as technical developments in HTS and rising pharmaceutical R&D spending are driving the global high throughput screening industry. In addition, demand development is projected to be powered by the growing research activities in stem cells & toxicology and emerging markets.
Strong capital spending, on the other hand, is expected to hamper demand growth during the projected period. In addition, the high time consumption and high cost of high-throughput screening techniques can impede the growth of the market.
Segmental Analysis
Based on product & service, technology, applications, end user, and region, the global high throughput screening market trend has been segmented.
The global market has been bifurcated into reagents & assay kits, instruments, consumables & accessories, software and services, based on product & service.
Segmental Analysis
The worldwide market is divided into cell-based assays, 2D cell culture, 3D cell culture, 3D cell culture, perfusion cell culture, laboratory-on-a-chip (LOC), ultra-high-throughput screening, bioinformatics, and label-free technology based on technology.
Based on use, the global market is segmented into target recognition & confirmation, primary and secondary screening, toxicology assessment, and others. Due to rising pharmaceutical R&D and the increasing prevalence of many diseases, the application category is projected to be the fastest-growing.
The global market is categorised into pharmaceutical and biotechnology firms, university and government agencies, contract research organisations, and others, depending on end users.
Regional Overview
North America and Latin America have been segmented into the high-performance scanning industry in the Americas, with the North American market split into the US and Canada.
Due to the rising per capita healthcare spending and the fast penetration of advanced technologies in the region, the demand in the Americas is projected to dominate the global high throughput screening market. It is expected that the will adoption of HTS in the US and Canada will fuel the growth of the sector. In addition, growing spending on research by healthcare institutions is expected to boost demand growth in this field.
In Europe, the market was projected to see a substantial amount of growth. The existence of a well-established healthcare sector and the participation of main corporations can be attributed to this.
Leading to a rise in chronic diseases and rising government measures for health care reforms, the Asia-Pacific market is expected to have a steady growth rate during the forecast period.
The Middle East & Africa market is estimated to account for the lowest share of the global market because of the region’s low per capita disposable income.
Competitive Dashboard
The key players operating in the global high throughput screening market are Aurora Biomed Inc. (Canada), Danaher (US), PerkinElmer (US), Tecan (Switzerland), Hamilton (US), Axxam (Italy), Merck Group (Germany), Corning (US), BioTek (US), Beckman Coulter, Inc. (US), Agilent Technologies Inc. (US), Luminex Corporation (US), and Roche (Switzerland).
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Synopsis
According to the research conducted by Market Research Future Reports (MRFR), the global fertility drug and surgery market is expected to witness a CAGR of 9.50 % during the forecast period of 2022-2030. Some of the major aspects influencing this growth include health factors such as a spike in global infertility rates, increased gamete donations, obesity, and delayed pregnancies. Some economic factors, such as a rise in disposable incomes and healthcare expenditure around the world, are other crucial factors growing the market. Further, a sedentary lifestyle across the globe is the leading cause of rising infertility, which appears to be boosting the demand for treatment and is driving the market growth. In addition to this, a shift from the traditional cultural viewpoint, the rising age of the average pregnant woman, increased health problems such as infertility and obesity, and a rampant surge in sexually transmitted diseases is pushing the boundaries for great expansion in the global market for fertility treatment. Thus, it is seen that increasing awareness about medical procedures is creating plenty of opportunities for the future of family planning. However, negative externalities such as high cost of treatment and medical complications may challenge the market growth during the forecast period.
Regional Analysis
The global fertility drug and surgery market research can be segmented on the basis of drug, underlying cause, end-user, procedures, and region.
On the basis of drugs, the global fertility drug and surgery market can be segmented on the basis of clomiphene citrate, letrozole, Serophene, hormone treatment, gonadotrophins.
On the basis of the underlying cause, the global fertility drug and surgery market can be segmented on the basis of male and female
On the basis of end-user, the global fertility drug and surgery market can be segmented on the basis of fertility clinics, hospitals, clinical research institutes, and others.
On the basis of procedures, the global fertility drug and surgery market can be segmented on the basis of hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), sperm retrieval (epididymal aspiration)
On the basis of region, the global fertility drug and surgery market can be segmented on the basis of the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Regional Analysis
The global market for fertility drugs and surgery is dominated by the Americas – owing to increasing infertility, obesity, and delayed pregnancies. From an economic perspective, an increase in the disposable income of an average American household adds to the boost in market growth. This trend is closely followed by Europe, who stood second in 2017 in the global fertility drug and surgery market.
On the other hand, Asia Pacific happens to be the fastest-growing region for this market. It is driven by factors such as increasing awareness amongst people and growing healthcare infrastructure in this region.
Lastly, the Middle East and Africa face issues such as abject poverty and failing economics, making the market lag within this region and causing it to have the least share in this market. However, between the Middle East and Africa, the former seems to hold a bigger portion of the market share owing to increased government funding in healthcare programs and the presence of more developed economies including UAE, Kuwait, and Saudi Arabia
Key Players
The established players of the global fertility drug and surgery market are Baxter Healthcare Corporation, Eli Lilly, Ferring Pharmaceuticals, Inc., Noven Pharmaceuticalorganon, Inc., Merck & Co. Pharmaceutical Company, Janssen Pharmaceuticals Inc., Pfizer, Inc., Procter & Gamble Pharmaceuticals, Personal Products Company, Emd Serono, Inc., and others.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Scope
The chlorhexidine gluconate (CHG) wipes market 2032 is all set to record a CAGR of 4.78 % from 2023 to 2032 (appraisal period), says Market Research Future (MRFR). MRFR also confirms that the market can accrue a valuation of USD 13948.89 thousand by end of 2023. We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.
Top Drivers and Barriers
Patients in hospitals, especially in ICUs, generally require more number of medical devices like ventilators and urinary catheters. These devices boost infection risk, if not cleaned effectively by the medical staff. This is where chlorhexidine gluconate/CHG comes into the picture, as it helps clean the equipment by killing the germs. It is said that everyday baths using CHG can curb the spread of various infections. Therefore, its use has mounted significantly since the COVID-19 outbreak, with the number of patients in hospital growing in light of the escalating pandemic, despite the global lockdown.
CHG’s benefits are plenty, some of which includes the fact that it has no side effects and helps control infections at surgical sites and in the central line-based bloodstream. It also helps prevent infections caused by multidrug-resistant organisms.
The striking rise in HAIs/hospital-acquired infections, accelerated number of surgical site infections and surgeries along with the expanding geriatric population worldwide has enhanced the market size significantly in recent years. Researches aimed at finding a COVID-19 breakthrough and to mitigate the health challenges associated with the virus have increased in recent months.
For instance, in August 2020, physicians from the University of Wisconsin School of Medicine and Public Health specializing in infectious diseases started exploring the potential of chlorhexidine gluconate in preventing SARS-CoV-2. The research caters to mainly frontline medical workers like nurses, respiratory therapists, doctors, nurse practitioners, pharmacists and nursing assistants, protecting from the virus.
Market Segmentation
The CHG wipes market has been considered for product type, concentration, application and distribution channel.
With respect to the product type, market has been split into CHG bath wipes as well as CHG/alcohol-based wipes.
The CHG wipes industry, depending on concentration, caters to 2% and 0.5%.
Application-wise key segments are central line-associated bloodstream infection, surgical site infection, lens cleaners and catheter-associated urinary tract infections. Between these, the value of the hospital and retail pharmacies segment in 2017 was USD 6,407.63.
Regional Study
The regional study of the chlorhexidine gluconate wipes market share covers Europe, APAC/Asia Pacific, the Middle East and Africa/MEA as well as the Americas.
In the following years, there are high chances of the American market emerging as the global leader, in view of the rising cases of chronic illnesses among people and the resultant surge in hospital admissions requiring surgeries. Increasing government support to the healthcare sector, primarily in bringing down the number of hospital-acquired infections can also strongly influence the chlorhexidine gluconate wipes market insights in the region.
Europe is one of the most lucrative markets in the world, thanks to the significant healthcare expenditure and the broadened awareness level with regard to hospital-acquired infections and surgical site infections.
The APAC market can soon record the fastest CAGR, with significant boost given by the widespread patient pool and the rapidly advancing healthcare industry across China, Japan and India. However, Australia emerged as the key market in 2017, with a share of 10.7% in the region.
Leading Industry Firms
The leading industry firms studied in the extensive study include Pal International, Cardinal Health, GAMA Healthcare Ltd, to name a few.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Overview
The Albumin (as Excipient) Market is expected to grow at a CAGR of 5.9% and is expected to reach a value of USD 1.46 billion during the forecast period. When it comes to the manufacture of drugs, the choice of excipient is crucial. Albumin has been proven to improve the lyophilized cake shape, the melting qualities of API from lyophilized granules, and the mobility of the drug substance when employed as an excipient in the preparation. The rising use of transgenic albumin-based drug carriers by biotechnology and pharmaceutical companies is one of the major factors driving the albumin industry. GlaxoSmithKline plc is using Novozymes Biopharma DK A/S’ albumin-based VELTIS breakthrough in the production of type II diabetic medications in Europe, according to a recent release.
The rising incidence of chronic diseases, technological innovations, the emergence of new markets in APAC and the Rest of the World, increased awareness of Albumin mas an excipient, and the rising use of Albumin for non-therapeutic implementations are all expected to contribute to the market’s continued growth. Due to a rise in the occurrence of life-threatening diseases and conditions, such as liver injury, infections, and cardiac surgery, hypoalbuminemia is becoming increasingly widespread. Growing acceptance of albumin products, development of albumin market outlook products for non-therapeutic purposes across various areas, and increased recognition of recombinant Albumin are all contributing to the market’s growth.
Market Segmentation
Based on the Application, the Albumin (as Excipient) Market Report has been segmented into in-vitro fertilization, medical device coating, drug formulation, vaccines, drug delivery, culture medium & stabilizers, diagnostics, and others.
Based on the end-users, the Albumin (as Excipient) Market has been segmented into academic and research organizations, the pharmaceutical and biotechnology sector, and others based on the propulsion types.
Based on the region, the Albumin (as Excipient) Market has been segmented into the Americas, Europe, Asia Pacific, the middle east, and Africa.
Regional Classification
The global market for Albumin was boosted by rising R&D spending and rising diabetes rates in the Americas. According to data from the Centers for Disease Control and Prevention (CDC), around 30.3 million Americans have diabetes. During the historic forecast period, Europe was anticipated to be the second-largest market for Albumin. This is due to technological advancements and increased market participation. During the historic forecast period, it was expected that the Asia-Pacific region would expand the fastest. The Asia Pacific region’s regional marketplaces are driven by an increase in medical spending. Between 2015 and 2016, the Australian Institute of Health and Welfare reported a total health investment of USD 181 billion. Even though albumin was most popular in Europe and North America, the Middle East and Africa had the smallest share of the total albumin market.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
The global report discussing the fetal bovine serum market size is expected to benefit a lot from the pharmaceutical sector. It could capitalize on the recent opportunities and mark a CAGR of 5.7 % during the forecast period of 2023 to 2030. The global market is expecting strong tailwinds from improvements in the research and development sector, increased funding from governments and private bodies, heightened demand from various traditional serum users, and its hike in expansion in the emerging nations.
However, the fetal bovine serum market may find it a bit difficult to grow in the coming years due to the financial crisis triggered by COVID-19.
Segmentation:
The global fetal bovine serum market, as in the report released by MRFR, has been segmented by application, product type, and end user. These segments hold various market dynamics and factors known for their influential contributions in furthering the market concerns. A deep look into these could reveal various pointers that can help companies in planning their moves.
By product type, the report on the fetal bovine serum market can be segmented into Charcoal Stripped, Dialyzed Fetal Bovine Serum (FBS), Chromatographic, Stem Cell, Exosome Depleted, and others. The stem cell segment has sub-segments like embryonic stem cells qualified, and mesenchymal stem cell qualified.
By application, the report discussing the fetal bovine serum market can be segmented into cell culture media, drug discovery, human & animal vaccine production, diagnostics, in-vitro fertilization, and others. The drug discovery segment would increase its intake due to the recent changes in market dynamics.
By end user, the report studies the market on the basis of pharmaceutical, biotechnology, research & academic institutes, and others. The pharmaceutical sector is expected to provide substantial market back up to the global market.
Regional Analysis:
The Americas has a chance to observe high growth in the market using which it would continue its domination. The regional market is slated to benefit from the presence of the US and Canada. These two countries are known for their extensive market contributions as their pharmaceutical sectors are providing various supports to the regional market. Europe would benefit from its extensive research and development facilities. Countries from the region would invest substantially in developing new drugs. In the Asia Pacific region, the inclusion of latest technologies in various sectors to boost industrial growth would ease the path for market percolation.
Competitive Landscape:
The global market for fetal bovine serum market trend is all set to benefit from the strategic moves controlled by Merck KGaA, HiMedia Laboratories, Atlanta Biologicals Inc., Bovogen Biologicals Pty Ltd, Tissue Culture Biologicals, TCS Biosciences Ltd, RThermo Fisher Scientific, Rocky Mountain Biologicals, GE Healthcare, PAN-Biotech, Bio-Techne, Nucleus Biologics, Access Biologicals, Animal Technologies Inc., Corning Incorporated, J R Scientific Inc., Biological Industries, Wisent Inc, Moregate Biotech, Zhejiang Tianhang Biotechnology Co. Ltd., and others. MRFR listed these companies and included their recent contributions to the market to understand the momentum of the market. This would also help in gauging market reactions to various pointers and as its result, strategy-devising processes would become simpler.
Industry News:
In March 2020, Wyoming witnessed a crisis in the viral transport medium to support the testing of various COVID-19. A recent find in the region has shown that the fetal bovine serum could be a safe medium to work with under such a distressful condition. This would increase the demand for the product and help the market expand. With the rising number of COVID-19 patients in the US, this could be a much-needed handy solution for doctors.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Global palliative care market is garnering huge traction over the past few years. The market growth attributes to the rising demand for improved care services and the rapidly growing healthcare sector worldwide. Palliative care aims at providing relief from symptoms of chronic diseases such as cancer, chronic obstructive pulmonary disease (COPD), cardiac diseases like congestive heart failure (CHF), kidney failure, Parkinson’s, Alzheimer’s, Amyotrophic Lateral Sclerosis (ALS), and many more.
Palliative care helps to improve the quality of life of patients and their families undergoing the problems of serious illness. Such benefits of palliative care accelerate market growth, increasing its adoption worldwide. The market is demonstrating colossal growth prospects on a global platform. According to Market Research Future (MRFR), the global palliative care market research is estimated to phenomenally by 2032, registering around 7.90 % CAGR throughout the forecast period (2023–2032).
Additionally, factors such as improving economic conditions worldwide and increasing healthcare expenses that are widening the access to quality care are influencing the market growth. Also, the improving quality of life of people acts as a significant driving force for the growth of the market.
Global Palliative Care Market – Segments
The report is segmented into four dynamics;
By Types : Private residence care, Hospice inpatient care, Hospital inpatient care, Nursing home, Residential facility care, and others.
By Applications : Cardiac diseases such as congestive heart failure (CHF), Chronic obstructive pulmonary disease (COPD), Cancer, Kidney failure, Parkinson’s, Alzheimer’s, Amyotrophic Lateral Sclerosis (ALS), and others.
By End-User : Hospitals, Home Care Settings, Palliative Care Centers, Long-Term Care Centers & Rehabilitation Centers, and others.
By Regions : North America, Europe, APAC, and Rest of the World.
Global Palliative Care Market – Regional Analysis
North America leads the global palliative care market. The largest market share attributes to the increasing prevalence of life-threatening diseases such as cancer, chronic obstructive pulmonary disease (COPD), cardiovascular diseases, kidney failure, Alzheimer’s disease, and others.
Furthermore, the presence of many notable players and the increasing number of specialty care centers foster regional market growth. Canada and the US are the major markets for palliative care in the region. Also, advances in medical technologies drive the growth of the market.
Europe stands second in the global palliative care market. The market growth is majorly led by government funding and support for the healthcare sector and increasing research & development activities. Moreover, growing numbers of palliative care centers in the region impact the growth of the market, extending application for homecare. Also, an increasing number of palliative care qualified physicians and rising geriatric population foster the growth of the market.
The Asia Pacific region is a promisingly growing market for palliative care globally. Factors such as the improving per capita healthcare expenses and the growing healthcare sector in the region drive the market growth. Moreover, the increasing advances in healthcare technologies and the rising number of specialty care centers in the region foster the growth of the APAC palliative care market.
Palliative Care Market – Competitive Analysis
Highly competitive, the palliative care market appears fragmented due to the presence of several well-established players. To gain a larger competitive share, brand reinforcement, mergers & acquisitions, and innovation remain popular trends of the key players. The market is expected to witness fierce competition due to the expected extensions in products and services.
Major Players
Players leading the global palliative care market include Skilled Healthcare Group Incorporated, Vitas Healthcare Corporation, Sunrise Senior Living LLC, Gentiva Health Services Incorporated, Kindred Healthcare Incorporated, Home Instead Senior Care Incorporated, Genesis HealthCare Corporation, and Amedisys Incorporated.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Scenario
Market Research Future (MRFR) assessed the global breast imaging market 2020 along the review period till 2025. From 2019 to 2025, the global breast imaging market is expected to thrive at 7.5% CAGR. during the forecast period. By 2025, the breast imaging market value can touch USD 4.9 Bn by 2025.
Breast imaging includes tools and technologies for screening, diagnosis, and detection, of breast cancer. Latest imaging technologies aid in the determination of stage and location of cancerous cells. The increase in adoption of breast imaging solutions to determine types of breast cancer and its condition to design effective treatment can underpin the market rise. The involvement of multiple manufacturers in research and development of effective prognosis can promote the global breast imaging market share across the forecast tenure.
However, causes, such as; stringent regulatory policies, and product recall can hamper the rise of the global breast imaging market.
Market Segmentation
The segment study of the global breast imaging market is based on technology and end users.
The technology-based segments of the breast imaging market are ionizing, and non-ionizing among others. The ionizing segment studied mammography, PET-CT, molecular breast-specific gamma imaging (BSGI) or molecular breast imaging (MBI), contrast enhanced spectral mammography (CESM), and cone beam computed tomography. The non-ionizing segment consists of breast ultrasound, breast thermography, breast MRI, electrical impedance imaging (EIT), and optical imaging. MRFR study states that the ionizing segment can secure the largest market share as physicians prefer opting for mammography for precise results.
The end user-based segments of the breast imaging market are specialty centers, and hospitals and clinics among others. The hospitals and clinics segment can register high CAGR, while the specialty centers can rise to acquire substantial profit by 2025. The worldwide market of breast imaging can be largely driven by technological advancements adopted by end-users to treat and contain surging cases of breast cancer. The introduction of symposiums and increase in conferences taken to spreading awareness about periodic screening and early diagnosis of cancer can contribute to the market rise. The favorable reimbursement scenario in hospitals can prompt market rise.
Detailed Regional Study
North America breast imaging market insight is expected to hold decent share of the overall market. The rapid rise in cases of breast cancer creating the need for innovative imaging solutions to offer accurate results are causes that are likely to contribute to the expansion of the regional market.
In Europe, the breast imaging market is presumed to show exponential growth owing to escalation of funding in research and development activities. The U.K., is expected to earn high revenue for the regional market, following Germany. The extensive application of available breast imaging technologies, along with other critical medical devices, can promote expansion of the regional market.
In Asia Pacific, the presence of numerous growth scopes as investors capitalize on the launch of new solutions can bolster APAC breast imaging market. The presence of some renowned companies in Japan, and India can add to the regional breast imaging market rise. The active spreading of awareness about breast cancer and increase in the deployment of modern medical devices for cancer screening are other causes that can favor the breast imaging market in the years to come.
Key Players
Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), GENERAL ELECTRIC COMPANY (US), Siemens Healthcare Private Limited (Germany), Hologic, Inc. (US), Dilon Technologies, Inc. (US), CMR Naviscan (US), SonoCiné (US), Supersonic Imagine (France), KUB Technologies (US), and PLANMED OY (Finland) are some major players in the global breast imaging market that are profiled by MRFR.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Scope
Market Research Future (MRFR) believes that the protein engineering market would capture an approximate CAGR of 6.2% from 2020 to 2027.
Prominent Boosters and Challenges
Protein engineering is widely utilized for circumventing issues and challenges attached with drugs, possessing the ability to elevate the efficacy and affinity of molecules for multiple applications, like cardiac repair. This has unprecedentedly fostered the demand as well as the adoption of protein engineering tools for developing advanced therapeutics, leading to rapid business progression. For example, advent of mAbs (recombinant Monoclonal Antibodies) is created by the extensive deployment of advanced protein engineering tools. The chimerization and humanization of mAbs as well as various approaches to better them in the vivo activity has given way to numerous alternatives for treating various types of cancers, autoimmune diseases, transplant rejections, and several conditions.
Growing urgency to cut down significant R&D expenditure in clinical studies is an important growth rendering factor in the global market. High costs are brought on by significant failure rates during the preclinical stage. The commercialization and marketing of new drug molecules is quite complex and results in long durations. Close to 40% of compounds witness failure during the early stages of the clinical trials, contributing significantly to the costs. This has thrown light on the importance of protein engineering tools among biotech and pharma firms, thereby adding to the revenues.
Market Segmentation
The protein engineering market research has been considered for type, method, application, and end-users.
Different types of protein engineering are reagents, services and software along with instrument.
Various methods studied in the MRFR report include rational protein design as well as directed evolution.
Major applications are environment applications, food and detergent industries, biopolymer production, nanobiotechnology, and medical applications.
Prominent end-users profiled in the market study include pharmaceuticals and biotechnology companies, contract engineering organizations, and academic research institutes.
Regional Status
The major regions across which the protein engineering industry will note growth during the review period are Americas, Asia Pacific, the Middle East and Africa, and Europe.
The North American market has been growing by leaps and bounds, successfully taking the lead backed by the extensive concentration of highly reputed players along with the exponential surge in the number of pharmaceutical and biotechnology firms. The biggest market in the region belongs to the US, while Canada comes a close second. The US market stands to benefit from the extensive use of protein engineering methods and technologies combined with the availability of sophisticated instruments and devices for use in research activities. Manufacturers in the region frequently enter partnerships and collaborations to foster their R&D capabilities while several pharmaceutical vendors are involved in commercializing advanced engineering tools. This helps create a favorable scenario for the protein engineering market in North America.
Europe is the second most profitable market and will continue to flourish, thanks to the surging usage of protein engineering technologies and methods. The incredible expansion of the research and development sector across the U.K., France, and Germany, also adds to the market’s gains in the region.
Asia Pacific will show the fastest growth trajectory in the following years, fuelled primarily by the surging burden of lifestyle disorders such as obesity, diabetes, heart diseases, and more. Soaring requirement for modern new technologies in the healthcare sector and the expanding presence of contract research organizations benefits the APAC industry as well.
Leading Companies
Waters Corp. (U.S), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), AB-Sciex (U.S.), Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), are some of the key manufacturers in the worldwide market.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Snapshot
As per the assessment by Market Research Future (MRFR), the global oral thin film drugs market is estimated to secure a valuation of USD 4,068.7 million and is expected to expand at a CAGR of 10.50% during the forecast period from 2018 to 2023.
Oral thin films (OTF) are loaded with active substance that are used for drug delivery via mouth. OTF drugs easily dissolve with saliva, therefore it is likely to gain traction, which can boost the oral thin film drugs market outlook 2020. Further, the minimal invasive attribute of OTF drugs is projected to be another key market driving factor. These drugs are likely to have a high acceptance rate due to its ease of application and high efficiency, which can induce major market gains during the forecast period. In addition, the incessant technical development in OTF drugs is likely to boost its demand and develop the market.
On the contrary, the high cost of treatment is projected to obstruct the market growth during the review period. However, its clinical benefits and rising geriatric population are likely to combat hampering causes, and boost the demand for OTF drugs.
Market Segmentation
The segment analysis of the global oral thin film drugs market is done by disease indication, product, and distribution channel.
The diseases indication based segments of the global oral thin film drugs market are migraine, schizophrenia, opioid dependence, and nausea and vomiting, and others. Among these segments, the migraine segment is estimated to grow at a robust pace during the forecast period.
The product-based segments of the global oral thin film drugs market are Fast Dissolving Buccal Film and sublingual.
The distribution channel based segments of the global oral thin film drugs market are retail pharmacies, hospital pharmacies, online drug stores, and others. The retail pharmacies are likely to procure the valuation of USD 1 9309.9 million by 2023.
Regional Analysis
Based on the region, the global oral thin film drugs market report is segmented into Europe, North America, Asia-Pacific, and the Middle East and Africa.
As per the research by MRFR, the OTF drugs market is likely to be led by the Americas during the forecast period owing to the presence of globally renowned players. Further, the developed healthcare sector with increased expenditure to avail medical facilities are projected to be other potent factors in market development in the region. The analysis reveals that the expansion of retail pharmacies in the region can assist the Americas in procuring the CAGR of 10.72% during the review period.
Europe is predicted to witness robust growth during the review period owing to the increased favorable initiatives taken by the government of various developed countries situated in the region. Further, rising healthcare funds are anticipated to drive the regional market significantly.
The APAC region is estimated to be a lucrative market during the forecast period owing to the presence of developing economies. The growing geriatric population in the region is estimated to play a crucial role in augmenting the regional market.
The MEA region is likely to experience slow growth due to the presence of sluggish economies, majorly in Africa. However, the well-developed countries like the UAE, Qatar, and others can make a significant contribution owing to sufficient healthcare budget.
Key Players
The renowned players of the global oral thin film drugs market are Indivior Plc (U.S.), Novartis AG (Switzerland), LTS Lohmann Therapie-Systeme AG (Germany), CURE Pharmaceutical (U.S.), GlaxoSmithKline Plc (U.K.), Pfizer Inc. (U.S.), and Johnson & Johnson Services, Inc. (U.S.).
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Scope
Market Research Future (MRFR) projects that the chronic kidney disease market will record a decent growth rate of 5.2% over the forecast timeframe (between 2020 and 2027).
Growth Boosters and Deterrents
Rising burden of chronic diseases across the world including kidney as well as high blood pressure has rendered the chronic kidney disease market size quite profitable. The Kidney Health Australia reveals that healthcare costs pertaining to the existing as well as new cases of kidney disease will touch USD 12 billion by 2022. Going forward, the Centers for Disease Control & Prevention says that close to 15% of Americans are expected to develop chronic kidney disease by 2021. Reports also confirm that a whopping 96% of patients suffering from kidney damage are not even aware of about the condition, which should foster the growth potential of the chronic kidney disease drugs industry in the years ahead. Alarming rise in cases of high blood pressure and diabetes is also bound to create favorable avenues for the global market.
Market Segmentation
The chronic kidney disease industry has been segregated with respect to diagnosis, treatment, indication, and end-user.
The diagnosis-based segments are urine test, blood test, kidney biopsy and imaging test.
Treatment-wise, the market caters to dialysis, kidney transplant and drugs.
The indications covered in the report are polycystic kidney disease, high blood pressure, Type 1 or Type 2 diabetes, and others.
Major market end-user considered in the study are diagnostic centers, hospitals and clinics, and others.
Regional Analysis
The chronic kidney disease industry has been geographically divided into Europe, APAC/Asia Pacific, MEA/Middle East & Africa and the Americas.
The American market for chronic kidney disease is in the lead, considering the expanding population of patients affected by kidney diseases and the extensive demand for kidney disease diagnostic tests. Soaring need for new and more effective treatment options for the condition has fostered the growth of the chronic kidney disease market growth. CDC reports that in the year 2015, close to 120,000 Americans started with the treatment for chronic kidney disease, indicating the rising awareness among the mass about this condition. This prompts more and more patients to come forward and seek treatment for the condition. This factor should ensure sustained market growth throughout the review period for North America.
The European market has been rendered strong by the burgeoning medical device sector and the mounting awareness among people about the risk factors associated with kidney diseases. Additionally, the mounting number of diabetic patients and the large-scale spending on the medical device and drugs industry will further elevate the market position in Europe. Germany is by far the most lucrative market for chronic kidney diseases in the region, in view of the rising emphasis on developing new drugs and the strong government backing to research & development activities.
Asia Pacific is slated to chart the fastest growth trajectory over the ensuing years, largely due to the expanding elderly population, prevalence of stressful lifestyle and the growing patient base. The noteworthy improvement in the quality of treatment lines and diagnosis, along with the surge in purchasing capacity of people across China, Japan and India also push the market demand.
Leading Companies
Siemens, Beckman Coulter, F. Hoffmann-La Roche Ltd, 77 Elektronika, AbbVie Inc., Inc., URIT Medical, Abbott, ARKRAY, OPTI Medical, Sysmex, Randox Laboratories, Teva Pharmaceutical Industries Ltd., ACON Laboratories, AstraZeneca Plc, Pfizer Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline Plc, Amgen Inc., Kissei Pharmaceutical Co. Ltd., Nova Biomedical are identified as the key contenders in the global market for chronic kidney disease.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com